ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy.
Wang C, Huang M, Lin Y, Zhang Y, Pan J, Jiang C, Cheng M, Li S, He W, Li Z, Tu Z, Fan J, Zeng H, Lin J, Wang Y, Yao N, Liu T, Qi Q, Liu X, Zhang Z, Chen M, Xia L, Zhang D, Ye W.
Wang C, et al.
Nat Metab. 2023 Oct;5(10):1765-1786. doi: 10.1038/s42255-023-00883-y. Epub 2023 Sep 4.
Nat Metab. 2023.
PMID: 37667133